Results 51 to 60 of about 27,667 (182)

Smoking and antidepressants pharmacokinetics: a systematic review [PDF]

, 2017
Despite an increasingly recognized relationship between depression and smoking, little is known about how smoking influences antidepressant response and treatment outcomes.
Donato, H, Madeira, N, Oliveira, P, Ribeiro, J   +3 more
core   +1 more source

Is there a potential of misuse for venlafaxine and bupropion? [PDF]

, 2018
© 2018 Schifano and Chiappini. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the ...
Anderson, Augustin, Baker, Baribeau, Bolden-Watson, Campagne, Carvalho, Chiappini, Chiappini, Chouinard, Cosci, Cutler, Deluca, Evans, Fava, Fava, Fountain, Francesconi, Groot, Harvey, Harvey, Hill, Hilliard, Holland, Hopper, Hu, Kantor, Kelly, Khurshid, Kim, Koga, Kotzalidis, Langguth, Lewin, Llorca, Maj, McCormick, Muth, Nelson, Orsolini, Parker, Phillips, Quaglio, Redrobe, Reeves, Renoir, Rettew, Rudolph, Sabljić, Schifano, Schifano, Shang, Shenouda, Sir, Stahl, Stahl, Stahl, Stall, Stassinos, Taylor, Vento, Weikop, Welsh, Wilson, Yoon   +64 more
core   +3 more sources

Duloxetine-Induced Sleep Bruxism and Tooth Fracture in Fibromyalgia

Düzce Tıp Fakültesi Dergisi
Duloxetine is a serotonin-norepinephrine reuptake inhibitor that is approved for the treatment of fibromyalgia. Duloxetine has many side effects such as nausea, somnolence, insomnia, decreased appetite, dry mouth, and constipation.
İsmail Tunçekin, Murat Toprak
doaj   +1 more source

The risk of bleeding with duloxetine treatment in patients who use nonsteroidal anti-inflammatory drugs (NSAIDs): analysis of placebo-controlled trials and post-marketing adverse event reports

Drug, Healthcare and Patient Safety, 2013
David G Perahia,1 Mark E Bangs,2 Qi Zhang,2 Yingkai Cheng,2 Jonna Ahl,2 Elijah P Frakes,2 Michael J Adams,2 James M Martinez2 1Neurosciences, Lilly Research Centre, Windlesham, Surrey, UK; 2Neurosciences, Eli Lilly and Company, Indianapolis, IN, USA ...
Perahia DG, Bangs ME, Zhang Q, Cheng Y, Ahl J, Frakes EP, Adams MJ, Martinez JM   +7 more
doaj  

Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials

BMC Neurology, 2008
Background Duloxetine hydrochloride is a reuptake inhibitor of 5-hydroxytryptamine and norepinephrine used to treat depression, generalized anxiety disorder, neuropathic pain, and stress incontinence in women.
Derry Sheena, Gaskell Helen, Sultan Asquad, Moore R Andrew   +3 more
doaj   +1 more source

Real-world treatment patterns and opioid use in chronic low back pain patients initiating duloxetine versus standard of care

Journal of Pain Research, 2013
Jeffrey Scott Andrews,1 Ning Wu,2 Shih-Yin Chen,2 Xia Yu,2 Xiaomei Peng,1 Diego Novick1 1Global Health Outcomes, Eli Lilly and Company, Indianapolis, IN, USA; 2Evidera, Lexington, MA, USA Abstract: To describe the use of pain medications in patients with
Andrews JS, Wu N, Chen SY, Yu X, Peng XM, Novick D   +5 more
doaj  

Duloxetine reduces opioid consumption and pain after total hip or knee arthroplasty: a meta-analysis of randomized controlled trials

Journal of Orthopaedic Surgery and Research
Purpose There is no consensus in the current literature on the analgesic role of duloxetine after total hip arthroplasty (THA) or total knee arthroplasty (TKA).
Yicai Lin, Mingyang Jiang, Chun Liao, Qingjian Wu, Jinmin Zhao   +4 more
doaj   +1 more source

Incontinence-specific quality of life measures used in trials of treatments for female urinary incontinence: a systematic review. [PDF]

, 2006
This systematic review examined the use of incontinence-specific QOL measures in clinical trials of female incontinence treatments, and systematically evaluated their quality using a standard checklist.
Drutz, H.P, Glazener, Cathryn Margaret Anne, Hay-Smith, E. J. C., Karahalios, A, Ross, S, Soroka, D   +5 more
core  

Differential effects of MDMA and methylphenidate on social cognition [PDF]

, 2014
Social cognition is important in everyday-life social interactions. The social cognitive effects of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') and methylphenidate (both used for neuroenhancement and as party drugs) are largely unknown.
Crockett, Molly J., Hysek, Cédric M., Liechti, Matthias E., Quednow, Boris B., Schmid, Yasmin, Simmler, Linda D.   +5 more
core   +1 more source

A Systematic Review of Efficacy, Safety, and Tolerability of Duloxetine

Frontiers in Psychiatry, 2020
Duloxetine is a serotonin-norepinephrine reuptake inhibitor approved for the treatment of patients affected by major depressive disorder (MDD), generalized anxiety disorder (GAD), neuropathic pain (NP), fibromyalgia (FMS), and stress incontinence urinary
Daniela Rodrigues-Amorim, José Manuel Olivares, José Manuel Olivares, José Manuel Olivares, Carlos Spuch, Tania Rivera-Baltanás   +5 more
doaj   +1 more source